Vilin Bio Med (NSE:VILINBIO) Moat Score: 0/10 (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VILINBIO Vilin Bio Med Ltd NSE:VILINBIO
69 GF Score
Price ₹44.70
GF Value ₹75.10
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vilin Bio Med Moat Score?

Vilin Bio Med has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Vilin Bio Med has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Vilin Bio Med might have No Moat - No discernible moat.

Vilin Bio Med  (NSE:VILINBIO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Vilin Bio Med Moat Score Related Terms

NSE:VILINBIO
69GF Score
Vilin Bio Med Ltd NSE:VILINBIO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vilin Bio Med (NSE:VILINBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Vilin Bio Med stock appears to be undervalued. The current stock price of ₹44.70 is trading 40.5% below its estimated GF Value™ of ₹75.10. GuruFocus considers Vilin Bio Med to be Possible Value Trap.

Key valuation signals for NSE:VILINBIO:

  • Moat Score: 0
  • GF Value™: ₹75.10 vs. price of ₹44.70 (40.5% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the NSE:VILINBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vilin Bio Med Business Description

Address Road No. 2, Banjara Hills, H. No. 8-2-269/S/43, Plot No. 43, Sagar Co-operative Housing Society, Khairatabad, Hyderabad, TG, IND, 500034
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules and Nutritional Food supplements.
69GF Score

Get the complete analysis for NSE:VILINBIO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹44.70
Price
₹75.10
GF Value